Cause of death with graft function among renal transplant recipients in an integrated healthcare system

Transplantation

Volumn 91, Issue 2, 2011, Pages 225-230

  Kahwaji, Joseph ^a   Bunnapradist, Suphamai ^b   Hsu, Jin Wen ^c   Idroos, Mohammed L ^c   Dudek, Ryszard ^c  

^a CEDARS SINAI MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c Southern California Kaiser Permanente ^*  (United States)

Author keywords

Cardiovascular disease; Death with graft function; Kidney transplant

Indexed keywords

ALBUMIN; HEMOGLOBIN;

ADULT; ARTICLE; BLOOD PRESSURE; CARDIOVASCULAR DISEASE; CAUSE OF DEATH; DIABETES MELLITUS; FEMALE; GRAFT RECIPIENT; GRAFT SURVIVAL; HEALTH CARE SYSTEM; HUMAN; INFECTION; KIDNEY FAILURE; KIDNEY GRAFT; MAJOR CLINICAL STUDY; MALE; NEOPLASM; PRIORITY JOURNAL; RETROSPECTIVE STUDY;

CALIFORNIA; CARDIOVASCULAR DISEASES; CAUSE OF DEATH; COHORT STUDIES; DELIVERY OF HEALTH CARE, INTEGRATED; FEMALE; GRAFT SURVIVAL; HEALTH MAINTENANCE ORGANIZATIONS; HUMANS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES;

EID: 78751647832     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e3181ff8754     Document Type: Article

References (37)

1. Ojo AO, Hanson JA, Wolfe RA, etal. Long-term survivalinrenal transplant recipients with graft function. Kidney Int 2000; 57: 307.
2. Ghods AJ, Ossareh S. Detection and treatment of coronary artery disease in renal transplantation candidates. Transplant Proc 2002; 34: 2415.
3. Kasiske BL, Guijarro C, Massy ZA, et al. Cardiovascular disease after renal transplantation. J Am Soc Nephrol 1996; 7: 158.
4. Fellström B. Risk factors for and management of post-transplantation cardiovascular disease. BioDrugs 2001; 15: 261.
5. Ostovan MA, Fazelzadeh A, Mehdizadeh AR, et al. How to decrease cardiovascular mortality in renal transplant recipients. Transplant Proc 2006; 38: 2887.
6. El-Amm JM, Haririan A, Crook ED. The effects of blood pressure and lipid control on kidney allograft outcome. Am J Cardiovasc Drugs 2006; 6: 1.
7. Kasiske BL, Anjum S, Shah R, et al. Hypertension after kidney transplantation. Am J Kidney Dis 2004; 43: 1071.
8. Ott U, Busch M, Steiner T, et al. Anemia after renal transplantation: An underestimated problem. Transplant Proc 2008; 40: 3481.
9. Guijarro C, Massy Z, Wiederkehr MR, et al. Serum albumin and mortality after renal transplantation. Am J Kidney Dis 1996; 27: 117.
10. Green AM. Electronic health records improving patient care in Wales. J (Inst Health Rec Inf Manag) 2008; 49: 20.
11. Shekelle PG, Morton SC, Keeler EB. Costs and benefits of health information technology. Evid Rep Technol Assess (Full Rep) 2006: 1.
12. Lee BJ, Forbes K. The role of specialists in managing the health of populations with chronic illness: The example of chronic kidney disease. BMJ 2009; 339: b2395.
13. Allen JK, Blumenthal RS, Margolis S, et al. Nurse case management of hypercholesterolemia in patients with coronary heart disease: Results of a randomized clinical trial. Am Heart J 2002; 144: 678.
14. Paez KA, Allen JK. Cost-effectiveness of nurse practitioner management of hypercholesterolemia following coronary revascularization. J Am Acad Nurse Pract 2006; 18: 436.
15. Stafford RS, Berra K. Critical factors in case management: Practical lessons from a cardiac case management program. Dis Manag 2007; 10: 197.
16. System URD. USRDS Annual Data Report 2009: Atlas of chronic kidney disease and end-stage renal disease in the United States. Bethesda, MD, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases 2009.
17. Weir MR. Blood pressure management in the kidney transplant recipient. Adv Chronic Kidney Dis 2004; 11: 172.
18. Tutone VK, Mark PB, Stewart GA, et al. Hypertension, antihyperten-sive agents and outcomes following renal transplantation. Clin Transplant 2005; 19: 181.
19. Raiss Jalali GA, Fazelzadeh A, Mehdizadeh AR. Effect of hypertension on transplant kidney function: Three year of follow-up. Transplant Proc 2007; 39: 941.
20. Opelz G, Döhler B; Collaborative Transplant Study. Improved long-term outcomes after renal transplantation associated with blood pressure control. Am J Transplant 2005; 5: 2725.
21. Kovesdy CP, Anderson JE, Kalantar-Zadeh K. Inverse association between lipid levels and mortality in men with chronic kidney disease who are not yet on dialysis: Effects of case mix and the malnutrition-inflammation-cachexia syndrome. J Am Soc Nephrol 2007; 18: 304.
22. Kilpatrick RD, McAllister CJ, Kovesdy CP, et al. Association between serum lipids and survival in hemodialysis patients and impact of race. J Am Soc Nephrol 2007; 18: 293.
23. ChavalitdhamrongD, Danovitch GM, Bunnapradist S. Is there a reversal of reverse epidemiology in renal transplant recipients? Semin Dial 2007; 20: 544.
24. Holdaas H, Fellström B, Jardine AG, et al. Effect of fluvastatin on cardiac outcomes in renal transplant recipients: A multicentre, randomised, placebo-controlled trial. Lancet 2003; 361: 2024.
25. Holdaas H, Fellström B, Cole E, et al. Long-term cardiac outcomes in renal transplant recipients receiving fluvastatin: The ALERT extension study. Am J Transplant 2005; 5: 2929.
26. Schaeffner ES, Födinger M, Kramar R, et al. Prognostic associations between lipid markers and outcomes in kidney transplant recipients. Am J Kidney Dis 2006; 47: 509.
27. Rauchhaus M, Coats AJ, Anker SD. The endotoxin-lipoprotein hypothesis. Lancet 2000; 356: 930.
28. Jamerson K, Weber MA, Bakris GL, etal. Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients. N Engl J Med 2008; 359: 2417.
29. Borrows R, Loucaidou M, Chusney G, et al. Anaemia and congestive heart failure early post-renal transplantation. Nephrol Dial Transplant 2008; 23: 1728.
30. Afzali B, Al-Khoury S, Shah N, et al. Anemia after renal transplantation. Am J Kidney Dis 2006; 48: 519.
31. Choukroun G, Deray G, Glotz D, et al. [Incidence and management of anemia in renal transplantation: An observational-French study]. Nephrol Ther 2008; 4: 575.
32. Gentil MA, Pérez-Valdivia MA, González-Roncero FM, et al. Treatment of anemia in renal transplantation: Impact of a stricter application of hemoglobin targets. Transplant Proc 2008; 40: 2916.
33. Imoagene-Oyedeji AE, Rosas SE, Doyle AM, et al. Posttransplantation anemia at 12 months in kidney recipients treated with mycophenolate mofetil: Risk factors and implications for mortality. J Am Soc Nephrol 2006; 17: 3240.
34. Berns JS, Fishbane S. CHOIR, CREATE, and anemia treatment in patients with CKD. Semin Dial 2007; 20: 277.
35. United States Renal Data Service: USRDS 2007 annual data report: Atlas ofchronic kidney disease and end stage renal diseasein the United States. Bethesda, MD, National Institutes of Health 2007.
36. Pham PT, Pham PC, Danovitch GM. Cardiovascular disease posttrans-plant. Semin Nephrol 2007; 27: 430.
37. Preis SR, Pencina MJ, Hwang SJ, et al. Trends in cardiovascular disease risk factors in individuals with and without diabetes mellitus in the Framingham Heart Study. Circulation 2009; 120: 212.